An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model
A combination therapy using Prussian blue nanoparticles (PBNP) as photothermal therapy (PTT) agents coated with CpG oligodeoxynucleotides, an immunologic adjuvant, as a nanoimmunotherapy (CpG‐PBNP‐PTT) for neuroblastoma (NB) is described. NB driven by MYCN amplification confers high risk and correla...
Main Authors: | Anshi Shukla, Juliana Cano-Mejia, Jaclyn Andricovich, Rachel A. Burga, Elizabeth E. Sweeney, Rohan Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2021-08-01
|
Series: | Advanced NanoBiomed Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/anbr.202100021 |
Similar Items
-
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma
by: Juliana Cano-Mejia, et al.
Published: (2020-10-01) -
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01) -
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
by: Prasoon Agarwal, et al.
Published: (2023-05-01) -
MYCN in Neuroblastoma: “Old Wine into New Wineskins”
by: Maria Braoudaki, et al.
Published: (2021-10-01) -
Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01)